We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Constellation Healthcare Technologies | LSE:CHT | London | Ordinary Share | CMN SHS USD0.0001 (DI/REG S) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 216.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMCHT
RNS Number : 3995P
Constellation Healthcare Tech, Inc
17 November 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES ---------------------------------------------------------------------------------------------------- 1. Identity of the issuer or Constellation Healthcare the underlying issuer Technologies Inc. of existing shares to which voting rights are attached: (ii) ----------------------------------------------------------- --------------------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): ---------------------------------------------------------------------------------------------------- An acquisition or disposal of voting rights X --------------------------------------------------------------- ----------------------------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached --------------------------------------------------------------- ----------------------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments --------------------------------------------------------------- ----------------------------------- An event changing the breakdown of voting rights --------------------------------------------------------------- ----------------------------------- Other (please specify): ---------------------------------------------------------- --- ----------------------------------- 3. Full name of person(s) City Financial Investment subject to the Company Limited, acting as notification obligation: Investment Manager and Authorised (iii) Corporate Director of the City Financial Absolute Equity Fund ----------------------------------------------------------- --------------------------------------- 4. Full name of shareholder(s) BNY Mellon Trust and Depositary (if different from 3.):(iv) as Trustee to the City Financial Absolute Equity Fund ----------------------------------------------------------- --------------------------------------- 5. Date of the transaction 15 November 2016 and date on which the threshold is crossed or reached: (v) ----------------------------------------------------------- --------------------------------------- 6. Date on which issuer 16 November 2016 notified: ----------------------------------------------------------- --------------------------------------- 7. Threshold(s) that is/are crossed or reached: (vi, vii) 5% ----------------------------------------------------------- --------------------------------------- 8. Notified details: ---------------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) ---------------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE -------------- -------------------------------- -------------------------------------------------------------------- Number Number Number Number of voting % of voting of of of shares rights rights Shares Voting (x) Rights -------------- --------------- --------------- ---------------- -------------------------- ---------------------- Direct Direct Indirect Direct Indirect (xi) (xii) -------------- ----------- ----------- ---------------- ----------- ------------- --------- ----------- USU210051004 4,638,375 4,638,375 4,548,375 4,548,375 4.98% --------------- --------------- ---------------- ----------- ------------- --------- ----------- B: Qualifying Financial Instruments ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of financial Expiration Exercise/ Number of voting % of voting instrument date Conversion rights that rights (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. ------------------ ------------- ----------------------------- ----------------- --------------------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date Conversion rights rights (xix, instrument (xvii) period instrument xx) (xviii) refers to ---------------- ------------- ------------- -------------- ----------------- ----------------------------------- Nominal Delta ---------------- ------------- ------------- -------------- ----------------- ------------- -------------------- Total (A+B+C) ---------------------------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights -------------------------------------------------------------- ------------------------------------------------------ 4,548,375 4.98% -------------------------------------------------------------- ------------------------------------------------------ 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) ----------------------------------------------------------------------------- N/A Proxy Voting: ----------------------------------------------------------------------------- 10. Name of the proxy holder: N/A ------------------------------------------------------- -------------------- 11. Number of voting rights proxy N/A holder will cease to hold: ------------------------------------------------------- -------------------- 12. Date on which proxy holder will N/A cease to hold voting rights: ------------------------------------------------------- -------------------- 13. Additional information: ------------------------------------------------------- -------------------- 14. Contact name: Chris Sturdee ------------------------------------------------------- -------------------- 15. Contact telephone number: +44 (0)20 7451 9600 ------------------------------------------------------- --------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUNARRNAAAAUA
(END) Dow Jones Newswires
November 17, 2016 02:01 ET (07:01 GMT)
1 Year Constellation Healthcare Chart |
1 Month Constellation Healthcare Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions